These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
||||||||||||||||
|
(State of Incorporation)
|
(I.R.S. Employer Identification No.)
|
||||||||||||||||
| Title of each class | Trading Symbol | Name of exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
|
|
☒
|
Accelerated filer
|
☐
|
|||||||||||
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
|||||||||||
|
Emerging growth company
|
|
|||||||||||||
|
March 31,
2025 |
December 31,
2024 |
||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Accounts receivable, net |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
| Property and equipment, net |
|
|
|||||||||
| Identifiable intangible assets, net |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Other non-current assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accrued payroll | $ |
|
$ |
|
|||||||
| Other current liabilities |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Long-term debt |
|
|
|||||||||
| Deferred income tax liabilities |
|
|
|||||||||
| Other long-term liabilities |
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
|
Commitments and contingencies (Note 6)
|
|
|
|||||||||
| Stockholders’ equity: | |||||||||||
|
Preferred stock, $
|
|
|
|||||||||
|
Common stock, $
|
|
|
|||||||||
| Paid-in capital |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Accumulated other comprehensive loss |
(
|
(
|
|||||||||
| Total stockholders’ equity |
|
|
|||||||||
| Total liabilities and stockholders’ equity | $ |
|
$ |
|
|||||||
| Three Months Ended | |||||||||||||||||||||||
| March 31, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Revenues | $ |
|
$ |
|
|||||||||||||||||||
| Costs of services |
|
|
|||||||||||||||||||||
| Gross profit |
|
|
|||||||||||||||||||||
| Selling, general, and administrative expenses |
|
|
|||||||||||||||||||||
| Amortization of intangible assets |
|
|
|||||||||||||||||||||
| Operating income |
|
|
|||||||||||||||||||||
| Interest expense, net |
(
|
(
|
|||||||||||||||||||||
| Income before income taxes |
|
|
|||||||||||||||||||||
| Provision for income taxes |
|
|
|||||||||||||||||||||
| Net income | $ |
|
$ |
|
|||||||||||||||||||
| Earnings per share: | |||||||||||||||||||||||
| Basic | $ |
|
$ |
|
|||||||||||||||||||
| Diluted | $ |
|
$ |
|
|||||||||||||||||||
| Shares and share equivalents used to calculate earnings per share: | |||||||||||||||||||||||
| Basic |
|
|
|||||||||||||||||||||
| Diluted |
|
|
|||||||||||||||||||||
| Reconciliation of net income to comprehensive income: | |||||||||||||||||||||||
| Net income | $ |
|
$ |
|
|||||||||||||||||||
| Foreign currency translation adjustment |
|
(
|
|||||||||||||||||||||
| Comprehensive income | $ |
|
$ |
|
|||||||||||||||||||
| Common Stock | Paid-in Capital | Retained Earnings | Other | Total | ||||||||||||||||||||||||||||||||||
| Shares | Par Value | |||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, 2025 | ||||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Stock-based compensation expense | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
| Issuances under equity plans |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
| Tax withholding on restricted stock vesting | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||
| Stock repurchase and retirement of shares |
(
|
— |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||
| Acquisition of TopBloc |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
| Other | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||
|
Balance at March 31, 2025
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Three Months Ended March 31, 2024 | ||||||||||||||||||||||||||||||||||||||
|
Balance at December 31, 2023
|
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Stock-based compensation expense | — | — |
|
— | — |
|
||||||||||||||||||||||||||||||||
| Issuances under equity plans |
|
— |
|
— | — |
|
||||||||||||||||||||||||||||||||
| Tax withholding on restricted stock vesting | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||
| Stock repurchase and retirement of shares |
(
|
— |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||
| Other | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||
| Net income | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||
|
Balance at March 31, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Three Months Ended | |||||||||||
| March 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash Flows from Operating Activities | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Amortization and depreciation |
|
|
|||||||||
| Stock-based compensation |
|
|
|||||||||
| Other |
|
|
|||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable |
(
|
|
|||||||||
| Prepaid expenses and income taxes |
(
|
|
|||||||||
| Accounts payable |
(
|
(
|
|||||||||
| Accrued payroll |
(
|
(
|
|||||||||
| Other |
(
|
(
|
|||||||||
| Net cash provided by operating activities |
|
|
|||||||||
| Cash Flows from Investing Activities | |||||||||||
| Cash paid for property and equipment |
(
|
(
|
|||||||||
| Cash paid for acquisitions, net of cash acquired |
(
|
|
|||||||||
| Net cash used in investing activities |
(
|
(
|
|||||||||
| Cash Flows from Financing Activities | |||||||||||
| Proceeds from long-term debt |
|
|
|||||||||
| Principal payments of long-term debt |
(
|
(
|
|||||||||
| Proceeds from employee stock purchase plan |
|
|
|||||||||
| Repurchase of common stock |
(
|
(
|
|||||||||
| Payment of employment taxes related to release of restricted stock awards |
(
|
(
|
|||||||||
| Net cash provided by (used) in financing activities |
|
(
|
|||||||||
| Effect of exchange rate changes on cash and cash equivalents |
|
|
|||||||||
| Net Decrease in Cash and Cash Equivalents |
(
|
(
|
|||||||||
| Cash and Cash Equivalents at Beginning of Year |
|
|
|||||||||
| Cash and Cash Equivalents at End of Period | $ |
|
$ |
|
|||||||
| Supplemental Disclosure of Cash Flow Information | |||||||||||
|
Cash paid for —
|
|||||||||||
| Income taxes | $ |
|
$ |
|
|||||||
| Interest | $ |
|
$ |
|
|||||||
| Operating leases | $ |
|
$ |
|
|||||||
|
Noncash transactions —
|
|||||||||||
| Operating lease right of use assets obtained in exchange for operating lease liabilities | $ |
|
$ |
|
|||||||
|
March 31,
2025 |
December 31,
2024 |
|||||||||||||
| Other current assets: | ||||||||||||||
| Prepaid expenses and income taxes | $ |
|
$ |
|
||||||||||
| Other |
|
|
||||||||||||
| $ |
|
$ |
|
|||||||||||
| Other non-current assets: | ||||||||||||||
| Operating lease right-of-use assets | $ |
|
$ |
|
||||||||||
| Other |
|
|
||||||||||||
| $ |
|
$ |
|
|||||||||||
| Other current liabilities: | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Operating lease liabilities |
|
|
||||||||||||
| Contract liabilities |
|
|
||||||||||||
| Other |
|
|
||||||||||||
| $ |
|
$ |
|
|||||||||||
| Other long-term liabilities: | ||||||||||||||
| Operating lease liabilities | $ |
|
$ |
|
||||||||||
| Other |
|
|
||||||||||||
| $ |
|
$ |
|
|||||||||||
| Identifiable intangible assets: | Estimated Useful Life in Years | |||||||||||||
| Customer relationships |
|
$ |
|
|||||||||||
| Internally-developed software |
|
|
||||||||||||
| Trademarks | Indefinite-lived |
|
||||||||||||
| $ |
|
|||||||||||||
| Goodwill | $ |
|
||||||||||||
| Commercial | Federal Government | Total | |||||||||||||||||||||
|
Balance as of December 31, 2023
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| Translation adjustment |
(
|
— |
(
|
||||||||||||||||||||
|
Balance as of December 31, 2024
|
|
|
|
||||||||||||||||||||
| Acquisition of TopBloc |
|
— |
|
||||||||||||||||||||
| Translation adjustment |
|
— |
|
||||||||||||||||||||
|
Balance at March 31, 2025
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
| Estimated Useful Life in Years | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||||||||||||||||||||||||||||||
| Subject to amortization: | |||||||||||||||||||||||||||||||||||||||||||||||
| Customer and contractual relationships |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| Non-compete agreements |
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
| Internally-developed software |
|
|
|
|
— | — | — | ||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Not subject to amortization: | |||||||||||||||||||||||||||||||||||||||||||||||
| Trademarks |
|
— |
|
|
— |
|
|||||||||||||||||||||||||||||||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||||
| Remainder of 2025 | $ |
|
|||
| 2026 |
|
||||
| 2027 |
|
||||
| 2028 |
|
||||
| 2029 |
|
||||
| Thereafter |
|
||||
| $ |
|
||||
|
March 31,
2025 |
December 31,
2024 |
||||||||||||||||||||||
| Senior Secured Credit Facility: | |||||||||||||||||||||||
|
$
|
$ |
|
$ |
|
|||||||||||||||||||
| Term loan B, due 2030 |
|
|
|||||||||||||||||||||
| Unsecured Senior Notes, due 2028 |
|
|
|||||||||||||||||||||
|
|
|
||||||||||||||||||||||
| Unamortized deferred loan costs |
(
|
(
|
|||||||||||||||||||||
| Term loan B, principal payments due in the next 12 months |
(
|
(
|
|||||||||||||||||||||
| Long-term debt | $ |
|
$ |
|
|||||||||||||||||||
| Three Months Ended | |||||||||||||||||||||||||||||||||||
| March 31, | |||||||||||||||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||||||||||||||
| Net income | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
|
Weighted-average number of common shares outstanding - basic
|
|
|
|||||||||||||||||||||||||||||||||
| Dilutive effect of common share equivalents |
|
|
|||||||||||||||||||||||||||||||||
|
Weighted-average number of common shares and share equivalents outstanding - diluted
|
|
|
|||||||||||||||||||||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Diluted earnings per share | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Three Months Ended March 31, 2025 | ||||||||||||||||||||
| Commercial | Federal Government | Total | ||||||||||||||||||
| Revenues | ||||||||||||||||||||
| Consulting | $ |
|
$ |
|
$ |
|
||||||||||||||
| Assignment |
|
|
|
|||||||||||||||||
|
|
|
|
||||||||||||||||||
| Costs of services |
|
|
|
|||||||||||||||||
| Gross profit |
|
|
|
|||||||||||||||||
| Segment depreciation and other amortization |
|
|
|
|||||||||||||||||
| Other segment expenses |
|
|
|
|||||||||||||||||
| Segment SG&A expenses |
|
|
|
|||||||||||||||||
| Amortization of intangible assets |
|
|
|
|||||||||||||||||
| Segment operating income |
|
|
|
|||||||||||||||||
| Corporate SG&A expenses |
|
|||||||||||||||||||
| Operating income |
|
|||||||||||||||||||
| Interest expense, net |
|
|||||||||||||||||||
| Income before taxes | $ |
|
||||||||||||||||||
| Three Months Ended March 31, 2024 | ||||||||||||||||||||
| Commercial | Federal Government | Total | ||||||||||||||||||
| Revenues | ||||||||||||||||||||
| Consulting | $ |
|
$ |
|
$ |
|
||||||||||||||
| Assignment |
|
|
|
|||||||||||||||||
|
|
|
|
||||||||||||||||||
| Costs of services |
|
|
|
|||||||||||||||||
| Gross profit |
|
|
|
|||||||||||||||||
| Segment depreciation and other amortization |
|
|
|
|||||||||||||||||
| Other segment expenses |
|
|
|
|||||||||||||||||
| Segment SG&A expenses |
|
|
|
|||||||||||||||||
| Amortization of intangible assets |
|
|
|
|||||||||||||||||
| Segment operating income |
|
|
|
|||||||||||||||||
| Corporate SG&A expenses |
|
|||||||||||||||||||
| Operating income |
|
|||||||||||||||||||
| Interest expense, net |
|
|||||||||||||||||||
| Income before taxes | $ |
|
||||||||||||||||||
| Three Months Ended | ||||||||||||||||||||||||||||||||||||||
| March 31, | ||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||||||||
| Firm-fixed-price | $ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| T&M |
|
|
||||||||||||||||||||||||||||||||||||
| Cost reimbursable |
|
|
||||||||||||||||||||||||||||||||||||
| $ |
|
|
||||||||||||||||||||||||||||||||||||
| Three Months Ended | ||||||||||||||||||||||||||||||||||||||
| March 31, | ||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | |||||||||||||||||||||||||||||||||||||
| Department of Defense and Intelligence Agencies | $ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| Federal Civilian |
|
|
||||||||||||||||||||||||||||||||||||
| Department of Homeland Security |
|
|
||||||||||||||||||||||||||||||||||||
| Other |
|
|
||||||||||||||||||||||||||||||||||||
| $ |
|
$ |
|
|||||||||||||||||||||||||||||||||||
| % of Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commercial | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consulting | $ | 290.1 | $ | 277.0 | 4.7 | % | 30.0 | % | 26.4 | % | 3.6 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Assignment | 382.1 | 454.5 | (15.9 | %) | 39.5 | % | 43.3 | % | (3.8 | %) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| 672.2 | 731.5 | (8.1 | %) | 69.4 | % | 69.7 | % | (0.3 | %) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Federal Government | 296.1 | 317.5 | (6.7 | %) | 30.6 | % | 30.3 | % | 0.3 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consolidated | $ | 968.3 | $ | 1,049.0 | (7.7 | %) | 100.0 | % | 100.0 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Profit | Gross Margin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commercial | $ | 217.7 | $ | 233.8 | (6.9 | %) | 32.4 | % | 32.0 | % | 0.4 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Federal Government | 57.7 | 62.4 | (7.5 | %) | 19.5 | % | 19.7 | % | (0.2 | %) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consolidated | $ | 275.4 | $ | 296.2 | (7.0 | %) | 28.4 | % | 28.2 | % | 0.2 | % | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended | Trailing-Twelve-Months Ended | |||||||||||||||||||||||||||||||||||||
| March 31, | March 31, | |||||||||||||||||||||||||||||||||||||
|
(Dollars in millions)
|
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||||||||||
| Bookings | $ | 336.9 | $ | 323.2 | $ | 1,295.0 | $ | 1,283.2 | ||||||||||||||||||||||||||||||
| Book-to-Bill Ratio |
1.2 to 1
|
1.2 to 1
|
1.1 to 1
|
1.2 to 1
|
||||||||||||||||||||||||||||||||||
| TTM Ended March 31, | |||||||||||
| (Dollars in millions) | 2025 | 2024 | |||||||||
| New Contract Awards | $ | 1,486.3 | $ | 1,144.3 | |||||||
| Book-to-Bill Ratio |
1.2 to 1
|
0.9 to 1
|
|||||||||
| (Dollars in millions) |
March 31,
2025 |
December 31,
2024 |
March 31,
2024 |
|||||||||||||||||
| Funded Contract Backlog | $ | 501.2 | $ | 529.0 | $ | 520.8 | ||||||||||||||
| Negotiated Unfunded Contract Backlog | 2,664.4 | 2,589.6 | 2,368.4 | |||||||||||||||||
| Contract Backlog | $ | 3,165.6 | $ | 3,118.6 | $ | 2,889.2 | ||||||||||||||
| Contract Backlog Coverage Ratio |
2.6 to 1
|
2.5 to 1
|
2.2 to 1
|
|||||||||||||||||
| Period | Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plan |
Approximate Dollar Value of Shares That May Yet be Purchased Under
the Plan (in millions) |
||||||||||||||||
| January 1 - 31, 2025 | 224,793 | $ | 88.96 | 224,793 | $ | 508.5 | ||||||||||||||
| February 1 - 28, 2025 | 340,405 | $ | 73.91 | 340,405 | $ | 483.4 | ||||||||||||||
| March 1 - 31, 2025 | 73,388 | $ | 64.71 | 73,388 | $ | 478.6 | ||||||||||||||
| Total | 638,586 | $ | 78.15 | 638,586 | $ | 478.6 | ||||||||||||||
| Number | Description | |||||||
| 3.1 | ||||||||
| 3.2 | ||||||||
| 3.3 |
|
|||||||
| 4.1 | Specimen Common Stock Certificate (incorporated by reference from an exhibit to the Company's Registration Statement on Form S-1 (File No. 33-50646) declared effective on September 21, 1992) (P) | |||||||
| 10.1* | ||||||||
| 10.2* | ||||||||
| 10.3* | ||||||||
| 10.4* | ||||||||
| 10.5* | ||||||||
| 31.1* | ||||||||
| 31.2* | ||||||||
| 32.1* | ||||||||
| 32.2* | ||||||||
| 101 | The following material from this Quarterly Report on Form 10-Q of ASGN Incorporated, Part I, Item 1 of this Form 10-Q formatted in Inline XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations and Comprehensive Income; (iii) Condensed Consolidated Statement of Stockholders’ Equity; (iv) Condensed Consolidated Statements of Cash Flows; and (v) related notes to these financial statements. | |||||||
| 104 | Cover page interactive data file (formatted in Inline XBRL and contained in Exhibit 101) | |||||||
| * | Filed herewith. | |||||||
| † | These exhibits relate to management contracts or compensatory plans, contracts or arrangements in which directors and/or named executive officers of the Registrant may participate. | |||||||
| (P) | This exhibit originally filed in paper format. Accordingly, a hyperlink has not been provided. | |||||||
| ASGN Incorporated | ||||||||
| April 30, 2025 | By: | /s/ Marie L. Perry | ||||||
| Marie L. Perry | ||||||||
| Executive Vice President and Chief Financial Officer | ||||||||
| (Principal Financial Officer and Duly Authorized Officer) | ||||||||
| April 30, 2025 | By: | /s/ Rose L. Cunningham | ||||||
| Rose L. Cunningham | ||||||||
| Vice President, Chief Accounting Officer and Controller | ||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|